Bismuth containing quadruple and concomitant therapy for 2 weeks are effective for the first-line Helicobacter pylori eradication: A prospective randomized trial

被引：0

作者：

Woo, H. ^{[1
]}

Chung, J. ^{[1
]}

Kim, S. ^{[1
]}

Kim, J. ^{[1
]}

Kwon, K. ^{[1
]}

Kim, K. ^{[1
]}

Kim, Y. ^{[1
]}

Park, D. ^{[1
]}

机构：

[1] Gachon Univ, Gil Med Ctr, Incheon, South Korea

来源：

HELICOBACTER | 2017年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P02.39

引用

页数：2

共 50 条

[1] Two-week bismuth-containing quadruple therapy and concomitant therapy are effective first-line treatments for Helicobacter pylori eradication: A prospective open-label randomized trial
Kim, So Jeong
Chung, Jun-Won
Woo, Hyun Sun
Kim, Su Young
Kim, Jung Ho
Kim, Yoon Jae
Kim, Kyoung Oh
Kwon, Kwang An
Park, Dong Kyun
WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (46) : 6790 - 6798
[2] Two-week bismuth-containing quadruple therapy and concomitant therapy are effective first-line treatments for Helicobacter pylori eradication: A prospective open-label randomized trial
So Jeong Kim
Jun-Won Chung
Hyun Sun Woo
Su Young Kim
Jung Ho Kim
Yoon Jae Kim
Kyoung Oh Kim
Kwang An Kwon
Dong Kyun Park
World Journal of Gastroenterology, 2019, 25 (46) : 6790 - 6798
[3] Sequential versus concomitant non-bismuth quadruple therapy as first-line eradication for helicobacter pylori
Pereira, F.
Azevedo, R.
Linhares, M.
Ramos, D.
Pinto, J.
Caldeira, A.
Tristan, J.
Pereira, E.
Sousa, R.
Banhudo, A.
NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
[4] Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial
Lee, Ju Yup
Kim, Nayoung
Park, Kyung Sik
Kim, Hyun Jin
Park, Seon Mee
Baik, Gwang Ho
Shim, Ki-Nam
Oh, Jung Hwan
Choi, Suck Chei
Kim, Sung Eun
Kim, Won Hee
Park, Seon-Young
Kim, Gwang Ha
Lee, Bong Eun
Jo, Yunju
Hong, Su Jin
BMC GASTROENTEROLOGY, 2016, 16
[5] Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial
Ju Yup Lee
Nayoung Kim
Kyung Sik Park
Hyun Jin Kim
Seon Mee Park
Gwang Ho Baik
Ki-Nam Shim
Jung Hwan Oh
Suck Chei Choi
Sung Eun Kim
Won Hee Kim
Seon-Young Park
Gwang Ha Kim
Bong Eun Lee
Yunju Jo
Su Jin Hong
BMC Gastroenterology, 16
[6] Non-bismuth quadruple therapy for first-line Helicobacter pylori eradication:A randomized study in Japan
Ayako Yanai
Kei Sakamoto
Masao Akanuma
Keiji Ogura
Shin Maeda
World Journal of Gastrointestinal Pharmacology and Therapeutics, 2012, (01) : 1 - 6
[7] Tailored eradication vs empirical bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: A comparative, open trial
Choi, Youn I.
Chung, Jun Won
Park, Dong Kyun
Kim, Kyoung Oh
Kwon, Kwang An
Kim, Yoon Jae
Seo, Ja Young
WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (46) : 6743 - 6751
[8] Tailored eradication vs empirical bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: A comparative,open trial
Youn I Choi
Jun Won Chung
Dong Kyun Park
Kyoung Oh Kim
Kwang An Kwon
Yoon Jae Kim
Ja Young Seo
World Journal of Gastroenterology, 2019, (46) : 6743 - 6751
[9] Bismuth containing quadruple therapy for second line Helicobacter pylori eradication
Lee, M.
Lee, B.
Kim, G.
Park, E.
Jeon, H.
Song, G.
HELICOBACTER, 2017, 22
[10] Comparison of the traditional triple and a new bismuth-containing quadruple therapy in the first-line eradication of Helicobacter pylori
Varga Mate
Dracz Lajos
Kolbenheyer Erik
Varga Ferenc
Patai Arpad, V
Solymosi Norbert
Patai Arpad
ORVOSI HETILAP, 2019, 160 (34) : 1340 - 1345

← 1 2 3 4 5 →